| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.6 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.6 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |